/ Pre-IPO Risk Index / Varda Space Industries

Varda Space Industries

Space (In-Space Manufacturing) · Pre-IPO · $900M (Q1 2025)
B-

Good (B-) — Round Z Pre-IPO Risk Grade

Varda Space Industries operates in-space pharmaceutical manufacturing — using microgravity for differentiated crystallization of pharmaceutical compounds. First successful re-entry mission 2024 (W-1).

74
Composite / 100
/ Subscore Breakdown · 5 Dimensions

Where this grade comes from.

Governance Risk
B
Valuation Methodology
B
Secondary Liquidity
C
Financial Disclosure
B-
Exit Probability
C+
/ Public-Record Events

Key risk events & disclosures.

  • W-1 first successful re-entry mission 2024
  • W-2, W-3 missions planned 2025-2026
  • Pharmaceutical customer relationships building
  • $90M Series C Q1 2025 at $900M

/ Best for

Investors with conviction on in-space manufacturing thesis and willingness to hold through commercial-scale validation.

/ Watch out for

In-space manufacturing economics remain unproven at commercial scale.